USPTO serial 99692567
FIERCE PHARMA WEEK
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- OESTREICHER, SALIMA PARMAR
- Law office
- TMEG LAW OFFICE 101
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with FIERCE PHARMA WEEK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Dover, DE, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Deborah J. Peckham
Deborah J. Peckham Barclay Damon LLP160 Federal Street, Suite 1001Boston, MA 02110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software in the nature of a mobile application used for networking at events for social media and for obtaining news and information in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing public policy information in the field of drugs; educational services, namely, arranging and conducting educational conferences, seminars and workshops in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations | ACTIVE | Sep 8, 2025 |
| 035 | Conducting, arranging, promoting and organizing trade shows, business conferences, business expos and buyer events for business purposes in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing public policy information in the field of drugs | ACTIVE | Aug 1, 2024 |
| 041 | Arranging and conducting trade shows, forums, meetings, conferences, and conventions in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing public policy information in the field of drugs; educational services, namely, arranging and conducting educational conferences, seminars and workshops in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations | ACTIVE | Aug 1, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Oct 27, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Sep 22, 2026 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jul 27, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 9, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 7, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 10, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 10, 2026 | NWAP | NEW APPLICATION ENTERED | — |